allicin has been researched along with interleukin-8 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Avidan, B; Bar-Meir, S; Bardan, E; Barshack, I; Chowers, Y; Fidder, HH; Hershkoviz, R; Lahav, M; Lang, A; Sakhnini, E | 1 |
Fu, P; Gu, X; Wu, H | 1 |
Jiang, L; Pan, H; Qiu, Z; Wang, X; Xu, Y; Zhang, M | 1 |
Alamir, AH; Patil, S | 1 |
4 other study(ies) available for allicin and interleukin-8
Article | Year |
---|---|
Allicin inhibits spontaneous and TNF-alpha induced secretion of proinflammatory cytokines and chemokines from intestinal epithelial cells.
Topics: Anti-Infective Agents; Caco-2 Cells; Chemokine CXCL10; Disulfides; Dose-Response Relationship, Immunologic; HT29 Cells; Humans; Immunosuppressive Agents; Interleukin-1; Interleukin-8; Intestinal Mucosa; RNA, Messenger; Sulfinic Acids; Tumor Necrosis Factor-alpha | 2004 |
Allicin attenuates inflammation and suppresses HLA-B27 protein expression in ankylosing spondylitis mice.
Topics: Animals; Disease Models, Animal; Disulfides; Gene Expression Regulation, Neoplastic; HLA-B27 Antigen; Humans; Inflammation; Interleukin-6; Interleukin-8; Mice; Mice, Transgenic; Spondylitis, Ankylosing; Sulfinic Acids; Tumor Necrosis Factor-alpha | 2013 |
Allicin Decreases Lipopolysaccharide-Induced Oxidative Stress and Inflammation in Human Umbilical Vein Endothelial Cells through Suppression of Mitochondrial Dysfunction and Activation of Nrf2.
Topics: Apoptosis; Cell Adhesion; Cytochromes c; Disulfides; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Interleukin-8; Lipid Peroxidation; Lipopolysaccharides; Liver X Receptors; Malondialdehyde; Membrane Potential, Mitochondrial; Mitochondria; Neutrophils; NF-E2-Related Factor 2; Oxidative Stress; Reactive Oxygen Species; RNA Interference; Sulfinic Acids; Tumor Necrosis Factor-alpha | 2017 |
Allicin Could Potentially Alleviate Oral Cancer Pain by Inhibiting "Pain Mediators" TNF-alpha, IL-8, and Endothelin.
Topics: AC133 Antigen; Antioxidants; Cancer Pain; Disulfides; Endothelins; Humans; Interleukin-8; Mouth Neoplasms; Neoplastic Stem Cells; Primary Cell Culture; Sulfinic Acids; Tumor Necrosis Factor-alpha | 2021 |